Gasoline Trading Firms to Pay $50 Million to Settle California Market Manipulation Claims
California AG Rob Bonta secured a $50 million settlement with two gasoline trading firms—Vitol Inc., and SK Energy Americas, Inc. and a related entity—to resolve allegations that the companies violated state competition laws by manipulating the market for gasoline after a refinery explosion.
READ MORE
Republican AGs Pen Amicus Challenging SEC’s Authority to Regulate Crypto
A group of 7 Republican AGs filed an amicus brief with the U.S. District Court for the Northern District of Texas in a litigation between the SEC and a company in the cryptocurrency space, arguing that the SEC does not have enforcement authority over cryptocurrencies.
READ MORE
FTC and FDA Warning Letters Continue to Weed Out Misleading Marketing of THC-Containing Products
The FTC and the FDA have sent cease-and-desist letters to five companies alleging that their marketing of edible products containing Delta-8 tetrahydrocannabinol violates Section 5 of the FTC Act because the packaging misleadingly imitates non-THC products that children regularly consume.
READ MORE
Democratic AGs Support HUD Rule Barring Discriminatory Impacts in Housing
A group of 18 Democratic AGs filed an amicus brief with the U.S. Court of Appeals for the D.C. Circuit in support of the Department of Housing and Urban Development’s (HUD) Discriminatory Effects Rule against a challenge by the National Association of Mutual Insurance Companies.
READ MORE
FTC Announces New Efforts Targeting Unfair and Deceptive Franchisor Practices
The FTC announced that it has taken multiple actions to address growing concern about unfair and deceptive practices by franchisors.
READ MORE
Democratic AGs File Amicus Brief Supporting Drug Pricing Transparency Law
A group of 21 Democratic AGs filed an amicus brief with the U.S. Court of Appeals for the Ninth Circuit supporting Oregon in its defense of H.B. 4005, which requires pharmaceutical manufacturers to report certain information about specific new prescription drugs and historical information about pricing for existing drugs.
READ MORE